Nicox

Read more
Michele Garufi's photo - Chairman & CEO of Nicox

Chairman & CEO

Michele Garufi

CEO Approval Rating

85/100

Founded:

1996

Status:

PublicIndependent CompanyPACOX

Annual Revenue
Employees
Sector

- -

NICOX TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Acucela is one of Nicox's top rivals. Acucela's headquarters is in Seattle, Washington, and was founded in 2002. Acucela operates in the Biotechnology industry. Acucela generates 93% of Nicox's revenue.

GENFIT has been one of Nicox's top competitors. GENFIT was founded in 1999 in Loos, Nord-Pas-de-Calais. GENFIT is in the Biotechnology industry. GENFIT generates $1.1M less revenue than Nicox.

DBV Technologies S.A is one of Nicox's top competitors. DBV Technologies S.A was founded in Montrouge, Île-de-France} in 2002. DBV Technologies S.A operates in the Biotechnology industry. Compared to Nicox, DBV Technologies S.A generates $1.1M more revenue.

Nicox Quarterly and Annual Revenue

Coming soon for Nicox!

Annual Revenue

$10.7M

Nicox's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 27.4M.

Nicox Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Laboratoires Doliage

Sep 2014

Source »
$6.5M
Doliage develops pharmaceutical products for ophthalmology.
Aciex Therapeutics, Inc.

Jul 2014

Source »
$120M
Aciex Therapeutics, an ophthalmic pharmaceutical company, develops a pipeline of prescription ophthalmic products.

Nicox Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Dec 2019
$8.9M

Kreos Capital

Private Placement
Nov 2019
$13.8M
Equity
Aug 2017
$31M
-

Nicox Investments

No recent investments found related to Nicox

Nicox News

Nicox Press Releases

Social Media

Nicox Headquarters

2405 route des Dolines – CS 10313 Drakkar 2 - Bat D, Sophia Antipolis

Valbonne, Provence-Alpes-Côte-d'Azur06560

33-4-97-24-53-00

Driving Directions »

Trending Companies

Nicox Summary

ABOUT

Overview

Nicox is a biotechnology company that discovers, develops and commercializes novel ophthalmic therapeutics for the treatment of eye diseases. Nicox was founded in 1996. Nicox's headquarters is located in Valbonne, Provence-Alpes-Côte-d'Azur, FR 06560...

CEO

Nicox's Chairman & CEO, Michele Garufi, currently has an approval rating of 85%. Nicox's primary competitors are Acucela, GENFIT & DBV Technologies S.A.

Website

nicox.com

Frequently Asked Questions about Nicox

  1. When was Nicox founded?

    Nicox was founded in 1996
  2. Who is Nicox's CEO?

    Nicox's CEO is Michele Garufi
  3. How much revenue does Nicox generate?

    Nicox generates $10.7M in revenue
  4. How much funding does Nicox have?

    Nicox has historically raised $53.7M in funding
  1. Where is Nicox's headquarters?

    Nicox's headquarters is in Valbonne Provence-Alpes-Côte-d'Azur, FR
  2. How many employees does Nicox have?

    Nicox has 34 employees
  3. Who are Nicox's competitors?

    Nicox's top competitors are Acucela, GENFIT, DBV Technologies S.A